GSE186486 SF3B1 DDX42 overexpression HEK293T 3 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE186486_SF3B1_DDX42 overexpression_HEK293T_3_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE186486_SF3B1_DDX42 overexpression_HEK293T_3_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE186486_SF3B1_DDX42 overexpression_HEK293T_3_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE186486_SF3B1_DDX42 overexpression_HEK293T_3_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

mir-99a-let-7c cluster host gene

Gene

JPX transcript, XIST activator

Gene

uncharacterized LOC101927164

Gene

ribosomal protein L36a pseudogene 21

Gene

taste 2 receptor member 12, pseudogene

Gene

MT-ND5 pseudogene 42

Gene

cubilin pseudogene 3

Gene

RNA, U1 small nuclear 75, pseudogene

Gene

shugoshin 1

Gene

mbt domain containing 1

  • Gene

    mir-99a-let-7c cluster host gene


  • Gene

    JPX transcript, XIST activator


  • Gene

    uncharacterized LOC101927164


  • Gene

    ribosomal protein L36a pseudogene 21


  • Gene

    taste 2 receptor member 12, pseudogene


  • Gene

    MT-ND5 pseudogene 42


  • Gene

    cubilin pseudogene 3


  • Gene

    RNA, U1 small nuclear 75, pseudogene



  • Gene

    mbt domain containing 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.